Skip to main content
Premium Trial:

Request an Annual Quote

Taiwan's Chang Gung Memorial Hospital Joins Japanese Cancer Genomic Screening Project

NEW YORK (GenomeWeb) — The National Cancer Center of Japan (NCC) said today that its Cancer Genomic Screening Project for Individualized Medicine (LC-SCRUM) has partnered with Chang Gung Memorial Hospital (CGMH) in Taiwan to expand its lung cancer genomic screening network.

LC-SCRUM was established in 2013 to screen target genes in lung cancer to advance the development of new drugs and diagnostics. To date, it has screened genes in over 7,000 patients in cooperation with over 200 medical institutions and pharmaceutical firms in Japan as well as with business development partner Premia.

NCC said that the addition of CGMH creates a regional cancer genomic screening network called LC-SCRUM-Asia.